More on PerkinElmer (PKI): Q4 EPS comes in line with estimates. Net losses narrowed on higher organic revenue plus an income-tax benefit. Human health segment revenue improved 6.5%. For FY13, the company forecast earnings of $2.24 to $2.32 a share, on organic revenue growth in the mid-single-digit range. Street expectations are for $2.32 per a share and growth of 4.8%, respectively.
More on PerkinElmer (PKI): Q4 EPS comes in line with estimates. Net losses narrowed on higher...
From other sites
at CNBC.com (May 5, 2014)
at CNBC.com (Apr 23, 2014)
at CNBC.com (Jan 29, 2014)
at CNBC.com (Dec 17, 2013)
at CNBC.com (Sep 16, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs